[Correlation of functional and structural changes of the cardiovascular system in hypertensive disease]

Fiziologicheskii Zhurnal SSSR Imeni I. M. Sechenova
|November 1, 1988
PubMed

Insights

Effective antihypertensive treatment reduces left ventricular mass and myocardial hypertrophy. However, forearm arterial resistance remains high due to increased smooth muscle activity, indicating persistent vascular changes in hypertension.

Area of Science:

  • Cardiovascular medicine
  • Hypertension research
  • Vascular physiology

Background:

  • Hypertension leads to cardiac and vascular structural changes.
  • Understanding the dynamics of these changes during treatment is crucial.

Purpose of the Study:

  • To investigate the effects of antihypertensive treatment on left ventricular mass, forearm arterial resistance, and venous compliance.
  • To explore the relationship between pressure reduction, myocardial hypertrophy regression, and vascular remodeling.

Main Methods:

  • Longitudinal study of hypertensive patients over 3 years.
  • Monitoring left ventricular mass, forearm arterial minimal resistance, and forearm venous compliance.
  • Assessing changes in relation to effective antihypertensive therapy.

Main Results:

  • Significant reduction in left ventricular mass and myocardial hypertrophy observed.
  • Forearm arterial minimal resistance remained elevated despite treatment.
  • Increased contractile activity of vascular smooth muscles contributes to persistent elevated resistance.

Conclusions:

  • Antihypertensive treatment effectively reduces cardiac hypertrophy.
  • Vascular structural changes, indicated by persistent elevated resistance, may require further therapeutic strategies.
  • Accurate assessment of structural changes necessitates standardized transmural pressure measurements.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...